CD8A and non-small cell lung carcinoma: Administration of IL-15 to NSCLC model mice previously infected with murine cytomegalovirus has been shown to selectively enhance the production of IFN-γ by these bystander CD8+ TILs, suggesting their potential utility in tumor immunotherapy [20].